Back to Search Start Over

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

Authors :
Boumpas, Dimitrios T.
Furie, Richard
Manzi, Susan
Illei, Gabor G.
Wallace, Daniel J.
Balow, James E.
Vaishnaw, Akshay
Source :
Arthritis & Rheumatism; Mar2003, Vol. 48 Issue 3, p719-727, 9p
Publication Year :
2003

Details

Language :
English
ISSN :
00043591
Volume :
48
Issue :
3
Database :
Complementary Index
Journal :
Arthritis & Rheumatism
Publication Type :
Academic Journal
Accession number :
62705143
Full Text :
https://doi.org/10.1002/art.10856